Advancing genomic medicine: The evolution of personalized cancer treatment in Japan The journey of cancer genomic medicine (CGM) began in the 1980s, with the discovery of various genomic and epigenomic alterations in cancer cells from various countries including Japan. This led to the development of molecular targeted therapies in the 2000s.
https://medicalxpress.com/news..../2024-04-advancing-g